GLP-1 Side Effects: A Complete Management Guide

A useful side-effect plan has two parts: knowing what may help with a mild symptom, and knowing when that symptom needs medical assessment. Start with the warning signs below if you feel unwell now.

This guide discusses semaglutide and tirzepatide used in weight-management care. The exact product, dose, other medicines and health history matter. It is not a dosing plan or a substitute for your medication’s instructions.

First, decide how urgently you need help

What is happening	What to do
Trouble breathing or swallowing, swelling of the face, lips, tongue or throat, or collapse	Call 911 or seek emergency care. A serious allergic reaction needs immediate treatment; stop the suspected medicine.
Severe abdominal pain that does not go away, sometimes extending to the back, with or without vomiting	Stop the medicine and seek medical help right away. This can be a warning sign of pancreatitis; do not wait for the next appointment.
Repeated vomiting, inability to keep fluids down, markedly reduced urination, or severe dizziness	Seek prompt medical assessment. Fluid loss can lead to dehydration and kidney problems. Use emergency care if symptoms are severe or you cannot obtain timely help.
Upper abdominal pain, fever, yellowing of the skin or eyes, or pale stools	Contact a clinician promptly for assessment of possible gallbladder problems; severe symptoms require urgent care.
Milder symptoms that keep returning, limit meals or fluids, or interfere with daily life	Contact the care team, especially before a planned dose increase. Do not assume they must be tolerated to continue treatment.

These actions reflect warnings and patient instructions in the Wegovy Medication Guide and Zepbound Medication Guide. This is not an exhaustive list, and a new symptom should not automatically be attributed to your medication.

Why symptoms can change during treatment

Semaglutide acts at GLP-1 receptors; tirzepatide acts at GIP and GLP-1 receptors. Both affect appetite and delay gastric emptying. Those effects help explain some digestive symptoms, but they do not prove the cause of every episode of nausea, diarrhea or abdominal pain. Wegovy clinical pharmacology, Zepbound clinical pharmacology.

Symptoms can emerge when treatment begins or a dose increases. In Zepbound’s weight-reduction trials, most nausea, vomiting and diarrhea events occurred during escalation and decreased over time. That group pattern does not establish a four-to-eight-week recovery deadline for you. Zepbound prescribing information, section 6.1.

Side-effect percentages also depend on the specific formulation, dose and study. A pooled range across different drugs is not your personal risk, and approved-product rates do not establish rates for a compounded preparation. For more on timing, see how long semaglutide side effects last.

Practical support for common symptoms

These suggestions are for mild symptoms while you remain able to eat and drink. Persistent or severe symptoms require review. The joint professional nutrition advisory supports individualized food and fluid adjustments alongside medical management.

Nausea and early fullness

Try smaller meals, eat slowly and pause when comfortably full. Large or very fatty meals may be harder to tolerate. A simple food you usually tolerate, such as rice or crackers, may be easier during a brief episode; it should not become your entire long-term diet.

Avoid a cycle of skipping all food because you feel nauseated and then trying to manage one large meal. Ask whether smaller, regular eating opportunities fit your plan. If meals remain difficult, the clinician can assess the dose and whether a prescription for symptom relief is appropriate. Some anti-nausea medicines can worsen constipation, so mention both symptoms. Joint advisory on gastrointestinal management.

For a focused guide, see semaglutide and nausea. Nausea is not evidence that you are losing more weight or need a stronger effect.

Vomiting

If you can drink, small sips may be easier than a large amount at once. Ask whether an oral rehydration solution fits your situation, especially if you have kidney or heart disease or a fluid restriction. Repeated vomiting or being unable to retain liquids warrants prompt assessment; do not use “24 hours” as a waiting rule.

Tell the care team how many episodes occurred, whether you can keep fluids down, whether urination has decreased and whether there is abdominal pain. This is more useful than describing vomiting simply as an expected adjustment. Wegovy dehydration warning.

Diarrhea

Focus on fluid intake appropriate for your health and foods you can comfortably tolerate. Large or high-fat meals may aggravate symptoms. Record how often diarrhea occurs and any associated pain, fever, blood or recent medication changes.

Ask before using an antidiarrheal medicine, particularly when symptoms are severe or there are other warning signs. Avoid automatically removing multiple food groups for days without a plan. Persistent diarrhea needs review even if you think the injection caused it. Joint nutrition advisory and Zepbound patient safety information.

Constipation

For uncomplicated constipation, gradual increases in fiber-containing foods, appropriate fluids and movement within your ability may help. A sudden large fiber increase is not always comfortable. Ask what to do if those steps are insufficient and which, if any, laxative is suitable.

Constipation with constant abdominal pain, vomiting, rectal bleeding or inability to pass gas requires medical attention rather than simply adding fiber. NIDDK constipation warning signs. Our semaglutide and constipation guide helps organize a follow-up discussion.

Fatigue, low energy and dizziness

Do not assume fatigue means you only need more protein. Review overall food intake, fluid intake, sleep and other medicines with the clinician, particularly if symptoms persist or affect your usual activities. There is no universal protein or water target appropriate for every patient. Our food guide explains how to discuss an individual plan.

Low blood sugar deserves special attention if you use insulin or a sulfonylurea. Shakiness, sweating, weakness, headache or confusion can be warning signs. Follow your prescribed glucose-monitoring and low-blood-sugar plan, and ask the prescriber whether your other medicines need adjustment. Severe confusion, seizures or loss of consciousness require emergency care. Wegovy and Zepbound hypoglycemia warnings; NIDDK guidance on severe hypoglycemia.

Headache

Headache is listed among Wegovy’s common adverse reactions; it should not automatically be dismissed as dehydration or reduced food intake. Note when it starts, what else is happening and whether it is persistent, severe or different from your usual headaches. Seek assessment for concerning symptoms.

Before adding a pain reliever, ask a clinician or pharmacist what is appropriate. In particular, ibuprofen and other NSAIDs can contribute to acute kidney injury when you are dehydrated. An over-the-counter label does not make a medicine suitable for every situation. Wegovy adverse reactions and NIDDK guidance on kidney-safe medicine choices.

Other symptoms and warnings to discuss

Reflux, belching and bloating: These appear in product adverse-reaction information. Mention persistent symptoms, foods that seem to aggravate them and any difficulty eating. The nutrition advisory notes that alcohol may worsen nausea or reflux. Joint advisory.

Thyroid warning: Wegovy and Zepbound carry boxed warnings about thyroid C-cell tumors observed in rodents; whether they cause these tumors in humans is unknown. Their contraindications include personal or family history of medullary thyroid carcinoma or MEN 2. Report a neck lump, persistent hoarseness or swallowing difficulty. Pancreatitis is a separate warning, not the boxed warning. Wegovy and Zepbound prescribing information.

Vision and planned procedures: Report vision changes, especially if you have diabetes. Tell every procedural team that you use the medicine before anesthesia or deep sedation, because delayed stomach emptying can affect aspiration risk. Get procedure-specific instructions instead of choosing a pause interval yourself. Wegovy and Zepbound warnings.

Dose changes belong in the symptom conversation

Approved Wegovy injection and Zepbound use gradual escalation to reduce gastrointestinal adverse reactions. The exact schedule differs by product; Wegovy’s label explicitly permits delaying an increase when a dose is not tolerated. Contact the prescriber before a planned increase if symptoms are ongoing. Wegovy dosing information, Zepbound dosing information.

Do not assume an evening injection prevents nausea, or change the amount or spacing of doses to experiment. An injection’s permitted time of day is not evidence that one time treats side effects. If a dose was missed or you vomited after an oral medicine, follow the instructions for that exact product and ask before taking an extra dose.

For broader context, see the semaglutide dosing guide. Compounded preparations are not FDA-approved; clarify their exact concentration and instructions with the prescriber and pharmacist rather than borrowing a branded product’s schedule. FDA information on unapproved GLP-1 products.

What to send your care team

A short, specific message can make the next conversation more useful:

• Exact product, prescribed dose and date of the last dose or increase.
• Symptom, when it began, and whether it is improving or worsening.
• Whether you can eat, drink and urinate normally.
• Any pain, fever, blood, dizziness or other new symptoms.
• Medicines, supplements or home remedies you have already tried.

Ask: “Do these symptoms need an examination or tests? What should I do before the next scheduled dose? If you recommend a symptom medicine, how should I use it, and when should I contact you again?”

You can review how REMEVi care works and the medical team when planning follow-up. If warning signs are present, seek the level of care described above instead of waiting for a routine message response.

This guide is educational and does not replace individual medical advice. Side effects, appropriate supportive care and dosing decisions depend on the exact medicine and your health history.